Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5.
Eric D YoungSharon J ManleyThomas C BeadnellAlexander E ShearinKen SasakiRosalyn ZimmermanEvan KauffmanCarolyn J VivianAishwarya ParasuramTomoo IwakumaPaul M GrandgenettMichael A HollingsworthMaura O'NeilDanny R WelchPublished in: British journal of cancer (2020)
Metastasis suppression by ITIH5 may be mediated by an intracellular mechanism. In human PDAC, loss of ITIH5 may be an early event and ITIH5-low PDAC cells in primary tumours may be selected for liver metastasis. Further defining the ITIH5-mediated pathway in PDAC could establish future therapeutic exploitation of this biology and reduce morbidity and mortality associated with PDAC metastasis.